Intensity Therapeutics to effect 1-for-25 reverse stock split on Feb 18 to meet Nasdaq bid price rule

INTENSITY THERAPEUTICS, INC.

Reverse split at 1-for-25 effective 4:01 p.m. ET Feb 18, 2026; post-split trading begins Feb 19.
Pre-split shares ~63,346,579; post-split ~2,533,863; authorized shares unchanged.
Purpose is to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
No fractional shares issued; cash payment in lieu at closing price on Feb 18, adjusted for split.
Stock symbol remains INTS; new CUSIP 45828J 202.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INTENSITY THERAPEUTICS, INC.: Filed amendment to certificate of incorporation to effect a 1-for-25 reverse stock split (effective 2026-02-13).

Change: charter amendment
Effective: 2026-02-13

Exact text from the filing

On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).

View on SEC.gov

37 governance changes filed in the last 30 days. Browse all governance changes →

INTENSITY THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001567264-26-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.